Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?

Abstract Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority. However, on closer analysis, the extern...

Full description

Bibliographic Details
Main Authors: Alexandru Achim, Adela Mihaela Serban, Stefan Dan Cezar Mot, Gregor Leibundgut, Madalin Marc, Ulrich Sigwart
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14272

Similar Items